Effects of prophylactic clarithromycin administration on quality of life in non-CF bronchiectasis patients Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections Year: 2014
Influence of inhaled glucocorticosteroids on course of the bronchiectasis Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015
Home versus hospital treatment of acute cystic fibrosis pulmonary exacerbations – Is quality of life really better at home? Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children Year: 2013
The low dose macrolides for prevention of exacerbations in non-CF bronchiectasis Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care Year: 2015
Nebulised colistimethate sodium improves quality of life in patients with bronchiectasis colonised by pseudomonas aeruginosa Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013
Understanding patients’ experience of living with non-cystic fibrosis bronchiectasis Source: Annual Congress 2013 –Aspects of physiotherapy in various clinical conditions and settings Year: 2013
Impact of bronchiectasis on the course of COPD Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations Year: 2016
Duration of inhaled corticosteroid therapy in children with asthma and frequency of community-acquired pneumonia in them Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma Year: 2016
Predicting hospital admissions in non-CF bronchiectasis using COPD specific severity tools Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients Year: 2013
Intranasal budesonide improves quality of life in patient with COPD and chronic nasal symptoms Source: International Congress 2016 – COPD diagnosis and management Year: 2016
Adherence with inhaled colistimethate sodium during a 6 month study in patients with non-cystic fibrosis bronchiectasis Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients Year: 2013
Validation of the Leicester Cough Questionnaire in non-cystic fibrosis bronchiectasis Source: Eur Respir J 2009; 34: 125-131 Year: 2009
Effectiveness of inhaled colistin by iNeb® device in non-CF bronchiectasis and chronic pseudomonas infection Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical and functional characterisation Year: 2015
Antibiotic treatment strategies in adults with bronchiectasis Source: Eur Respir Mon 2011; 52: 211-222 Year: 2011
Impact of bronchiectasis on duration of hospitalization in patients with exacerbations of COPD Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015
Validation of a Spanish version of the Leicester cough questionnaire in adult patients with non-cystic fibrosis bronchiectasis Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in different chronic conditions Year: 2013
Effect of nintedanib on cough and health related quality of life in patients with idiopathic pulmonary fibrosis Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016
Predictors of severe asthma exacerbations, poor asthma control and beta-agonist overuse in adult asthma Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013
Aetiology of non-CF bronchiectasis in adults and its association to quality of life Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies Year: 2017
The association between objective CT measures of bronchiectasis and health-related quality of life in COPD Source: International Congress 2014 – Monitoring COPD with different biomarkers Year: 2014